PSMD14 and osteosarcoma: To investigate if inhibiting PSMD14 contributes functionally to anlotinib resistance, anlotinib was used to treat OS-R (osteosarcoma resistant to anlotinib) and PSMD14-knockdown OS-R cell lines.